LeadingBiotech convenes biopharma leaders at its inaugural South CEO conference to be held on Oct. 8, 2019 at the New Orleans BioInnovation Center in Louisiana. The event provides an opportunity for industry leaders to network and leverage insight from discussions at the intersection of biotech, healthcare and innovation.
NEW ORLEANS (PRWEB) SEPTEMBER 25, 2019
LeadingBiotech, an exclusive event series bringing together senior-level biopharma leaders through off-the-record collaboration and dialogue, today announces its inaugural South CEO conference to be held on October 8, 2019 at the New Orleans BioInnovation Center in Louisiana.
Co-produced by Tulane University, this invitation-only meeting convenes biopharma executives to discuss pressing issues facing the industry. The inaugural event provides an opportunity for industry leaders to network and leverage insight from discussions at the intersection of biotech, healthcare and innovation.
“We are thrilled to be partnering with Tulane and bringing one of our esteemed executive-level conferences to the South,” said Wendy Nelson, Ph.D., CEO, LeadingBiotech “Building biotech companies outside of the Boston and San Francisco ‘hubs’ presents unique challenges and issues for CEO’s and their leadership teams, which will be addressed in this forum.”
To secure a spot at the conference, register here.
Key topics at this year’s conference include: Technology Shifting the Landscape & How It Works with Biotech, Company Building Outside the “Hubs,” BD Licensing Strategies and the VC Landscape: Looking in New Places for Innovation.
Speakers at the conference include:
- Brandon Allgood, CTO and Co-Founder, Numerate, Inc.
- Dorothy Lou Bailey, Head of Corporate Development & Strategy, Blackthorn Therapeutics
- Chris Garabedian, CEO, Xontogeny, Portfolio Manager, Venture for Perceptive Advisors
- Andrew Krouse, MALS, President and CEO, Cavion, Inc.
- Darrell Langois, SVP Strategy & BD, Blue Cross Blue Shield LA
- Susan Nichols, CEO, Falcon Therapeutics
See full agenda here.
About LeadingBiotech
Formerly known as Boston Biotech Conferences, LeadingBiotech is an event series that brings biopharma CEOs and leaders together through intimate, off-the-record collaboration. We are working hard to create more valuable experiences to re-energize discussions and infuse fresh ideas to better shape the future of biotech. For more information, please visit: https://leadingbiotech.com/.
Building biotech companies outside of the Boston and San Francisco ‘hubs’ presents unique challenges and issues for CEO’s and their leadership teams, which will be addressed in this forum. – Wendy Nelson, Ph.D., CEO, LeadingBiotech
